Drospirenone in HRT?

@article{2009DrospirenoneIH,
  title={Drospirenone in HRT?},
  author={},
  journal={Drug and Therapeutics Bulletin},
  year={2009},
  volume={47},
  pages={41 - 44}
}
  • Published 1 April 2009
  • Medicine
  • Drug and Therapeutics Bulletin
Drospirenone is a synthetic progestogen contained, with estradiol, in the hormone replacement therapy (HRT) product ▼Angeliq (Bayer Schering Pharma). This combination is licensed for the relief of oestrogen-deficiency symptoms in women who are at least 1 year postmenopausal.1 It is also licensed for prevention of osteoporosis in women at high risk of future fractures who are intolerant of, or have contraindications to, other medicinal products approved for the prevention of osteoporosis.1 It… 
1 Citations

Update on Newer Antihypertensive Medicines

AngQb vaccine in hypertensive patients showed a marked reduction in early morning blood pressure without serious adverse events and an endothelin-receptor antagonist such as bosentan significantly lowered blood pressure in patients with essential hypertension.